Viewing Study NCT00412620


Ignite Creation Date: 2025-12-25 @ 4:23 AM
Ignite Modification Date: 2026-03-10 @ 11:28 PM
Study NCT ID: NCT00412620
Status: TERMINATED
Last Update Posted: 2011-04-27
First Post: 2006-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia
Sponsor: Abbott
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: M06-816
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Beatrice Rendenbach-Mueller, PhD, Project Director, Neuroscience/Anesthesia Department
Old Organization: Abbott Laboratories

Collaborators